230 related articles for article (PubMed ID: 34597435)
1. Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers.
Ren J; Pang W; Hueniken K; Haddad G; Hope A; Huang SH; Spreafico A; Hansen AR; Perez-Ordonez B; Goldstein DP; Bratman SV; Zhang W; Zhao Y; Xu W; de Almeida JR; Liu G
Cancer; 2022 Feb; 128(3):497-508. PubMed ID: 34597435
[TBL] [Abstract][Full Text] [Related]
2. Patient-Reported Symptom Severity, Health-Related Quality of Life, and Emotional Distress Trajectories During and After Radiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A TROG 12.01 Secondary Analysis.
McDowell L; Bressel M; King MT; Corry J; Kenny L; Porceddu S; Wratten C; Macann A; Jackson JE; Rischin D
Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1110-1125. PubMed ID: 36868523
[TBL] [Abstract][Full Text] [Related]
3. Baseline MD Anderson Symptom Inventory Score is Strongly Associated With Patient-reported Acute and Late Toxicity Following (Chemo) Radiotherapy for Head and Neck Cancers.
Barker CL; Price GJ; Lee LW; McPartlin A
Clin Oncol (R Coll Radiol); 2022 Oct; 34(10):683-689. PubMed ID: 35688777
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported outcomes of symptom burden in patients receiving surgical or nonsurgical treatment for low-intermediate risk oropharyngeal squamous cell carcinoma: A comparative analysis of a prospective registry.
Amit M; Hutcheson K; Zaveri J; Lewin J; Kupferman ME; Hessel AC; Goepfert RP; Brandon Gunn G; Garden AS; Ferraratto R; Dave Fuller C; Tam S; Gross ND
Oral Oncol; 2019 Apr; 91():13-20. PubMed ID: 30926057
[TBL] [Abstract][Full Text] [Related]
5. Validation of the MD Anderson Symptom Inventory-Head-and-Neck-Filipino (MDASI-HN-F): clinical utility of symptom screening among patients with head-and-neck cancer.
Bacorro WR; Sy Ortin TT; Suarez CG; Mendoza TR; Que JC
BMJ Support Palliat Care; 2017 Jun; 7(2):140-149. PubMed ID: 25941198
[TBL] [Abstract][Full Text] [Related]
6. Nomogram for predicting symptom severity during radiation therapy for head and neck cancer.
Sheu T; Fuller CD; Mendoza TR; Garden AS; Morrison WH; Beadle BM; Phan J; Frank SJ; Hanna EY; Lu C; Cleeland CS; Rosenthal DI; Gunn GB
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):619-26. PubMed ID: 25104816
[TBL] [Abstract][Full Text] [Related]
7. Long-term Patient-Reported Outcomes in a Population-Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal Cancer.
Dohopolski MJ; Diao K; Hutcheson KA; Akhave NS; Goepfert RP; He W; Lei XJ; Peterson SK; Shen Y; Sumer BD; Smith BD; Sher DJ
JAMA Otolaryngol Head Neck Surg; 2023 Aug; 149(8):697-707. PubMed ID: 37382943
[TBL] [Abstract][Full Text] [Related]
8. M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy - A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Viganò A; De Felice F; Iacovelli NA; Alterio D; Facchinetti N; Oneta O; Bacigalupo A; Tornari E; Ursino S; Paiar F; Caspiani O; Di Rito A; Musio D; Bossi P; Steca P; Jereczek-Fossa BA; Greco A; Orlandi E
Oral Oncol; 2021 Apr; 115():105189. PubMed ID: 33549926
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
[TBL] [Abstract][Full Text] [Related]
10. Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language.
Sánchez D; Chala A; Alvarez A; Payan C; Mendoza T; Cleeland C; Sanabria A
J Pain Symptom Manage; 2016 Jun; 51(6):1055-61. PubMed ID: 26899822
[TBL] [Abstract][Full Text] [Related]
11. The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-reported symptoms in oropharyngeal cancer: Application of a mixed-model analysis of a prospective observational cohort registry.
van Dijk LV; Mohamed ASR; Ferrarotto R; McCoy LA; Sharafi CS; Jones E; Steele K; Moreno AC; Lai SY; Garden AS; Myers JN; Rosenthal DI; Fuller CD; Hutcheson KA;
Cancer; 2021 Jul; 127(14):2453-2464. PubMed ID: 33788956
[TBL] [Abstract][Full Text] [Related]
12. Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors.
Aggarwal P; Zaveri JS; Goepfert RP; Shi Q; Du XL; Swartz M; Gunn GB; Lai SY; Fuller CD; Hanna EY; Rosenthal DI; Lewin JS; Piller LB; Hutcheson KA
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1066-1076. PubMed ID: 30193299
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
Falchook AD; Green R; Knowles ME; Amdur RJ; Mendenhall W; Hayes DN; Grilley-Olson JE; Weiss J; Reeve BB; Mitchell SA; Basch EM; Chera BS
JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):517-23. PubMed ID: 27149571
[TBL] [Abstract][Full Text] [Related]
14. Symptom burden among head and neck cancer patients in the first year after diagnosis: Association with primary treatment modality.
Allen-Ayodabo CO; Eskander A; Davis LE; Zhao H; Mahar AL; Karam I; Singh S; Gupta V; Bubis LD; Moody L; Barbera L; Coburn NG
Oral Oncol; 2019 Dec; 99():104434. PubMed ID: 31630058
[TBL] [Abstract][Full Text] [Related]
15. The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis.
Rosenthal DI; Mendoza TR; Chambers MS; Burkett VS; Garden AS; Hessell AC; Lewin JS; Ang KK; Kies MS; Gning I; Wang XS; Cleeland CS
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1355-61. PubMed ID: 18501527
[TBL] [Abstract][Full Text] [Related]
16. Assessing patient-reported symptom burden of long-term head and neck cancer survivors at annual surveillance in survivorship clinic.
Townes TG; Navuluri S; Pytynia KB; Gunn GB; Kamal MJ; Gilmore KR; Chapman PH; Bell KV; Fournier DM; Janik MA; Joseph LM; Zendehdel S; Hutcheson KA; Goepfert RP
Head Neck; 2020 Aug; 42(8):1919-1927. PubMed ID: 32112621
[TBL] [Abstract][Full Text] [Related]
17. The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group.
Mendoza TR; Zhao F; Cleeland CS; Wagner LI; Patrick-Miller LJ; Fisch MJ
Clin Breast Cancer; 2013 Oct; 13(5):325-34. PubMed ID: 23816985
[TBL] [Abstract][Full Text] [Related]
18. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module.
Rosenthal DI; Mendoza TR; Fuller CD; Hutcheson KA; Wang XS; Hanna EY; Lu C; Garden AS; Morrison WH; Cleeland CS; Gunn GB
Cancer; 2014 Jul; 120(13):1975-84. PubMed ID: 24711162
[TBL] [Abstract][Full Text] [Related]
19. Quality of life changes over time and predictors in a large head and neck patients' cohort: secondary analysis from an Italian multi-center longitudinal, prospective, observational study-a study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group.
Viganò A; De Felice F; Iacovelli NA; Alterio D; Ingargiola R; Casbarra A; Facchinetti N; Oneta O; Bacigalupo A; Tornari E; Ursino S; Paiar F; Caspiani O; Di Rito A; Musio D; Bossi P; Steca P; Jereczek-Fossa BA; Caso L; Palena N; Greco A; Orlandi E
Support Care Cancer; 2023 Mar; 31(4):220. PubMed ID: 36930353
[TBL] [Abstract][Full Text] [Related]
20. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing.
; Grant S; Kamal M; Mohamed ASR; Zaveri J; Barrow MP; Gunn GB; Lai SY; Lewin JS; Rosenthal DI; Wang XS; Fuller CD; Hutcheson KA
Cancer; 2019 May; 125(10):1654-1664. PubMed ID: 30633325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
